» Articles » PMID: 36609231

A Systematic Review and Meta-analysis of the Association Between Sarcopenia and Myocardial Infarction

Overview
Journal BMC Geriatr
Publisher Biomed Central
Specialty Geriatrics
Date 2023 Jan 7
PMID 36609231
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Systematic review and meta-analysis of the association between sarcopenia and the development of myocardial infarction.

Methods: PubMed, Cochrane Library, and Embase were searched for studies on the association between sarcopenia and myocardial infarction from their inception until November 26, 2022. The fixed-effects model was used to calculate the combined risk ratio (RR) of sarcopenia in patients with myocardial infarction. Sensitivity analysis was used to test the robust of the combined result, and funnel plot were used to test publication bias.

Results: Five studies were included finally. There was no significant association between sarcopenia and risk of developing myocardial infarction [RR = 1.01; 95% CI = 0.94, 1.08; P = 0.317]. The sensitivity analysis showed robust of the combined result. The funnel plot showed no significant publication bias.

Conclusion: Limited evidence suggests no definitive association between sarcopenia and risk of myocardial infarction.

Citing Articles

A sarcopenia prediction model based on the calf maximum muscle circumference measured by ultrasound.

Wei A, Zou Y, Tang Z, Guo F, Zhou Y BMC Geriatr. 2025; 25(1):81.

PMID: 39910436 PMC: 11796220. DOI: 10.1186/s12877-025-05733-y.


Sarcopenia and Cardiogeriatrics: The Links Between Skeletal Muscle Decline and Cardiovascular Aging.

Anagnostou D, Theodorakis N, Hitas C, Kreouzi M, Pantos I, Vamvakou G Nutrients. 2025; 17(2).

PMID: 39861412 PMC: 11767851. DOI: 10.3390/nu17020282.


Disparities in the Prevalence of Hospitalizations and In-Hospital Mortality Due to Acute Myocardial Infarction Among Patients with Non-Alcoholic Fatty Liver Disease: A Nationwide Retrospective Study.

Hayat U, Kamal F, Kamal M, Mirza W, Ahmad T, Gangwani M J Clin Med. 2024; 13(22).

PMID: 39598090 PMC: 11595205. DOI: 10.3390/jcm13226946.

References
1.
Antunes A, Araujo D, Verissimo M, Amaral T . Sarcopenia and hospitalisation costs in older adults: a cross-sectional study. Nutr Diet. 2017; 74(1):46-50. DOI: 10.1111/1747-0080.12287. View

2.
Sato R, Okada K, Akiyama E, Konishi M, Matsuzawa Y, Nakahashi H . Impact of sarcopenic obesity on long-term clinical outcomes after ST-segment elevation myocardial infarction. Atherosclerosis. 2021; 335:135-141. DOI: 10.1016/j.atherosclerosis.2021.08.038. View

3.
Gao J, Deng M, Li Y, Yin Y, Zhou X, Zhang Q . Resistin as a Systemic Inflammation-Related Biomarker for Sarcopenia in Patients With Chronic Obstructive Pulmonary Disease. Front Nutr. 2022; 9:921399. PMC: 9315354. DOI: 10.3389/fnut.2022.921399. View

4.
Cook D, Reed D . Appraising the quality of medical education research methods: the Medical Education Research Study Quality Instrument and the Newcastle-Ottawa Scale-Education. Acad Med. 2015; 90(8):1067-76. DOI: 10.1097/ACM.0000000000000786. View

5.
Sato R, Akiyama E, Konishi M, Matsuzawa Y, Suzuki H, Kawashima C . Decreased Appendicular Skeletal Muscle Mass is Associated with Poor Outcomes after ST-Segment Elevation Myocardial Infarction. J Atheroscler Thromb. 2020; 27(12):1278-1287. PMC: 7840163. DOI: 10.5551/jat.52282. View